Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.92541 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.75779 | 63 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.72564 | 62 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.11624 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.7244 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.77002 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.75777 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.74466 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.70688 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.89475 | 65 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.74381 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.73263 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.80702 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.67579 | 62 |